<DOC>
	<DOC>NCT02955368</DOC>
	<brief_summary>The purpose of this study is to determine superiority of DP-R212 comparing to each monotherapy in patient with hypertension and primary hypercholesterolemia.</brief_summary>
	<brief_title>Clinical Trial to Evaluate the Efficacy and Safety of DP-R212</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<criteria>Both man and woman who is over 19 years old Hypertension patient with hypercholesterolemia sSBP difference is ≥20mmHg or sDBP difference is ≥10mmHg A history of cardiovascular disease rhabdomyolysis, myopathy Hypertension or hypercholesterolemia due to secondary causes Uncontrolled diabetes Evidence of hepatic or renal disease</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>DP-R212</keyword>
</DOC>